Data through close

Option volume activity

Which liquid chains traded the most option volume relative to existing open interest on Oct 8, 2026?

Total daily option volume divided by total open interest. This highlights turnover and new attention but does not distinguish opening from closing trades. Data through close. Descriptive only, not a recommendation.

At a glance

50 tickers qualified. First five: SPXW (0.89), QQQ (0.85), SPY (0.73), MMED (0.62), NDX (0.58).

Option volume activity as of Oct 8, 2026 close
# Ticker Close Open interest Volume/OI
1 SPXW 7,762.05 5,086,124 0.89
2 QQQ 747.58 12,241,583 0.85
3 SPY 773.93 18,356,858 0.73
4 MMED 19.80 168,806 0.62
5 NDX 30,725.81 198,202 0.58
6 SOXS 33.79 210,949 0.49
7 VSAT 67.41 160,990 0.42
8 MU 1,035.84 3,420,556 0.32
9 MDT 87.75 285,221 0.30
10 XSP 776.55 813,648 0.30
11 MAT 16.58 166,572 0.30
12 SKHY 170.50 946,471 0.28
13 FIGR 27.60 130,894 0.27
14 VIXW 15.56 154,637 0.27
15 RCL 281.39 110,540 0.27
16 PLTR 198.78 3,429,542 0.27
17 HUT 79.59 279,273 0.27
18 TQQQ 80.23 1,481,898 0.27
19 SOXL 142.52 1,503,611 0.26
20 APLD 23.85 919,651 0.25
21 SNDK 1,609.46 968,501 0.25
22 AAOI 105.90 372,345 0.24
23 IWM 277.63 10,668,320 0.24
24 TSLA 375.00 5,644,406 0.24
25 FCEL 17.25 215,837 0.24
26 CBRS 167.92 303,865 0.24
27 SQQQ 33.39 481,077 0.23
28 CMG 32.65 917,561 0.23
29 NBIS 219.71 1,424,985 0.23
30 SPCX 160.57 4,730,380 0.23
31 GME 25.28 1,915,605 0.23
32 MGM 30.01 267,599 0.22
33 AAPL 340.42 4,903,010 0.22
34 MSTR 151.47 2,681,718 0.22
35 SPXS 23.77 200,184 0.22
36 HUM 387.12 178,592 0.21
37 UVIX 35.06 117,389 0.21
38 PEP 128.34 419,490 0.21
39 IREN 35.71 2,955,494 0.20
40 INTC 107.08 6,307,039 0.20
41 NVDA 230.48 14,835,313 0.20
42 NUAI 4.83 279,448 0.20
43 BRUN 12.10 145,582 0.19
44 HD 295.47 294,310 0.19
45 WDC 393.31 536,601 0.19
46 MCD 236.90 455,379 0.19
47 MUU 34.26 180,923 0.19
48 BE 272.82 1,008,043 0.19
49 SBUX 93.21 476,750 0.19
50 ORCL 135.55 3,489,389 0.18

Screens describe what the data shows after the close. They are not trade recommendations; see the disclaimer and the methodology.